Corporate Responsibility
Schering-Plough is committed to improving the health and well-being of people throughout the world. In fulfilling that commitment, we are developing new treatments and programs that assist patients in achieving their best possible therapeutic outcomes. We are also working with public and private organizations to improve access to prescription medications around the world. In the United States, an important part of these efforts involves our patient assistance programs and patient support programs.
Schering-Plough provides lifesaving drugs at no cost through our patient assistance programs to people with low incomes who do not have prescription drug coverage.
Informal patient assistance programs have been in place at Schering-Plough since the early 1980s. Today, patients can apply for assistance through two programs: Commitment to Care, which covers our cancer and hepatitis drugs; and Schering-Plough-Cares, which includes our other prescription drugs. In 2007, these programs provided more than 60,000 patients with over $100 million worth of free Schering-Plough products.
Schering-Plough also donates products and provides financial support for programs that benefit patients in developing countries. In 2007, we donated more than $30 million worth of products for use by patients in underserved areas around the world.
Through the Schering-Plough Foundation and the Schering-Plough Charitable Contributions Program we are dedicated to working with the citizens of our communities to help them realize their full potential and enhance their quality of life. We strive to be good corporate citizens and to help improve the lives of the people in the communities where we live and work.
Schering-Plough also has a sound compliance program in place. Our internal compliance program is referred to as the “Leading with Integrity” Compliance Program and is one of the key components that help the company achieve its vision to “earn trust, every day.” Schering-Plough is in full compliance with the California Drug Marketing Practices Statute effective July 1, 2005.
